Safety and efficacy of everolimus with exemestane vs. Exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2

  1. Pritchard, K.I.
  2. Burris III, H.A.
  3. Ito, Y.
  4. Rugo, H.S.
  5. Dakhil, S.
  6. Hortobagyi, G.N.
  7. Campone, M.
  8. Csöszi, T.
  9. Baselga, J.
  10. Puttawibul, P.
  11. Piccart, M.
  12. Heng, D.
  13. Noguchi, S.
  14. Srimuninnimit, V.
  15. Bourgeois, H.
  16. Gonzalez Martin, A.
  17. Osborne, K.
  18. Panneerselvam, A.
  19. Taran, T.
  20. Sahmoud, T.
  21. Gnant, M.
Revista:
Clinical Breast Cancer

ISSN: 1938-0666 1526-8209

Any de publicació: 2013

Volum: 13

Número: 6

Pàgines: 421-432.e8

Tipus: Article

DOI: 10.1016/J.CLBC.2013.08.011 GOOGLE SCHOLAR lock_openAccés obert editor